Sandres-Saune K - Search Results

1

Factors accelerating liver fibrosis progression in renal transplant patients receiving ribavirin monotherapy for chronic hepatitis C.

Kamar N, Boulestin A, Selves J, Esposito L, Sandres-Saune K, Stébenet M, Chatelut E, Durand D, Rostaing L, Izopet J. Kamar N, et al. J Med Virol. 2005 May;76(1):61-8. doi: 10.1002/jmv.20323. J Med Virol. 2005. PMID: 15778976

2

Genetic heterogeneity of the envelope 2 gene and eradication of hepatitis C virus after a second course of interferon-alpha.

Boulestin A, Sandres-Sauné K, Payen JL, Alric L, Dubois M, Pasquier C, Vinel JP, Pascal JP, Puel J, Izopet J. Boulestin A, et al. J Med Virol. 2002 Oct;68(2):221-8. doi: 10.1002/jmv.10192. J Med Virol. 2002. PMID: 12210411 Clinical Trial.

3

Long-term ribavirin therapy in hepatitis C virus-positive renal transplant patients: effects on renal function and liver histology.

Kamar N, Sandres-Saune K, Selves J, Ribes D, Cointault O, Durand D, Izopet J, Rostaing L. Kamar N, et al. Am J Kidney Dis. 2003 Jul;42(1):184-92. doi: 10.1016/s0272-6386(03)00422-0. Am J Kidney Dis. 2003. PMID: 12830471 Clinical Trial.

4

Amantadine therapy in renal transplant patients with hepatitis C virus infection.

Kamar N, Rostaing L, Sandres-Saune K, Ribes D, Durand D, Izopet J. Kamar N, et al. J Clin Virol. 2004 May;30(1):110-4. doi: 10.1016/j.jcv.2003.10.001. J Clin Virol. 2004. PMID: 15072764 Clinical Trial.

5

Effects of long-term lamivudine therapy in renal-transplant patients.

Kamar N, Sandres-Saune K, Ribes D, Duffaut M, Selves J, Durand D, Izopet J, Rostaing L. Kamar N, et al. J Clin Virol. 2004 Dec;31(4):298-303. doi: 10.1016/j.jcv.2004.07.001. J Clin Virol. 2004. PMID: 15494273

6

Follow-up of 28 HCMV seropositive renal-transplant recipients: comparison of clinical, biological and virological parameters in the groups of treated versus untreated infected patients.

Kamar N, Mengelle C, Yahyaoui S, Sandres-Sauné K, Durand D, Izopet J, Rostaing L. Kamar N, et al. J Clin Virol. 2005 May;33(1):35-42. doi: 10.1016/j.jcv.2004.09.028. J Clin Virol. 2005. PMID: 15797363

7

Natural history of hepatitis C virus-related liver fibrosis after renal transplantation.

Kamar N, Rostaing L, Selves J, Sandres-Saune K, Alric L, Durand D, Izopet J. Kamar N, et al. Am J Transplant. 2005 Jul;5(7):1704-12. doi: 10.1111/j.1600-6143.2005.00918.x. Am J Transplant. 2005. PMID: 15943629 Free article.

8

Intrahepatic cytokine profile in renal-transplant patients infected by hepatitis C virus.

Kamar N, Rostaing L, Sandres-Saune K, Selves J, Barthe C, Dubois M, Alric L, Durand D, Izopet J. Kamar N, et al. J Med Virol. 2005 Aug;76(4):482-8. doi: 10.1002/jmv.20387. J Med Virol. 2005. PMID: 15977245

9

Incidence of HCV infection in French hemodialysis units: a prospective study.

Izopet J, Sandres-Sauné K, Kamar N, Salama G, Dubois M, Pasquier C, Rostaing L. Izopet J, et al. J Med Virol. 2005 Sep;77(1):70-6. doi: 10.1002/jmv.20415. J Med Virol. 2005. PMID: 16032714

10

Twenty-four hour kinetics of hepatitis C virus and antiviral effect of alpha-interferon.

Boulestin A, Kamar N, Sandres-Sauné K, Legrand-Abravanel F, Alric L, Vinel JP, Rostaing L, Izopet J. Boulestin A, et al. J Med Virol. 2006 Mar;78(3):365-71. doi: 10.1002/jmv.20548. J Med Virol. 2006. PMID: 16419107

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

66 results

Search Page

Filters